Structure Therapeutics (GPCR) Accumulated Expenses (2022 - 2026)

Quarterly Accumulated Expenses rose 83.96% to $46.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Mar 2026, up 83.96% year-over-year, with the annual reading at $12.4 million for FY2025, 77.0% up from the prior year.

Structure Therapeutics' Accumulated Expenses history spans 5 years, with the latest figure at $46.6 million for Q1 2026.

  • Accumulated Expenses came in at $46.6 million for Q1 2026, up from $12.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $46.6 million in Q1 2026 to a low of $1.1 million in Q1 2023.
  • The 5-year median for Accumulated Expenses is $8.1 million (2023), against an average of $14.3 million.
  • The largest YoY upside for Accumulated Expenses was 1137.46% in 2025 against a maximum downside of 70.3% in 2025.
  • Structure Therapeutics' Accumulated Expenses stood at $6.7 million in 2022, then skyrocketed by 175.3% to $18.6 million in 2023, then crashed by 62.15% to $7.0 million in 2024, then skyrocketed by 77.0% to $12.4 million in 2025, then surged by 274.4% to $46.6 million in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Accumulated Expenses are $46.6 million (Q1 2026), $12.4 million (Q4 2025), and $36.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46.55 Mn
Dec 31, 2025 12.43 Mn
Sep 30, 2025 36.93 Mn
Jun 30, 2025 5.59 Mn
Mar 31, 2025 25.31 Mn
Dec 31, 2024 7.03 Mn
Sep 30, 2024 5.17 Mn
Jun 30, 2024 18.82 Mn
Mar 31, 2024 2.05 Mn
Dec 31, 2023 18.56 Mn
Sep 30, 2023 4.59 Mn
Jun 30, 2023 9.24 Mn
Mar 31, 2023 1.15 Mn
Dec 31, 2022 6.74 Mn